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INSTEAD trial and the known adverse affects of a patent false lumen after
aortic dissection, studies such as this focusing on variables that can be
identified after dissection as possible indicators for early endovascular ther-
apy are clearly needed. Although patients with Marfan syndrome are not
thought to be optimal candidates for endovascular treatments, non-Marfan
patients with large proximal aortic tears and large aortas would seem to be
two subgroups that would benefit from further study for “prophylactic”
endovascular thoracic aortic repair after acute thoracic aortic resection.
Meta-Analysis of Individual Patient Data to Examine Factors Affecting
Growth and Rupture of Small Abdominal Aortic Aneurysms
Sweeting MJ, Thompson SG, Brown LC, et al; RESCAN collaborators. Br
J Surg 2012;99:655-65.
Conclusion:Risk factors differ for growth and rupture of small abdom-
inal aortic aneurysms (AAAs). In addition to aneurysm diameter, diabetes
and smoking may need to be considered in developing schedules for surveil-
lance of small AAAs. No single drug for cardiovascular risk reduction has a
pronounced affect on rupture or growth of small AAAs.
Summary: It is now well established that screening for AAAs can
reduce aneurysm-related mortality. Individual aneurysm and patient-specific
factors affecting small AAA growth rate and rupture potential are not well
established. Rupture of a small AAA is infrequent, and because most studies
are small, there are little convincing data about factors that might affect risk
of rupture of a small AAA. In addition, studies of growth rates of small AAAs
have made minimal attempts to adjust for the multiplicity of potential risk
factors in patients with AAA or to identify modifiers of aneurysm growth rate
such as diabetes or smoking (Bergqvist D, Eur J Vasc Endovasc Surg
2011;41:663-1; and Powel JT et al, Br J Surg 2011;98:609-19; and Brady
AR et al, Circulation 2004;110:16-21). In this report the authors used
individual patient data from 15,000 people under follow-up for a small
AAA to identify whether any of the common cardiovascular risk factors or
classes of drugs used by patients with aneurysms influence growth and
rupture rates of small AAAs. The authors requested individual patient data
from corresponding authors of 25 studies that included 100 patients with
a small AAA. Eighteen studies provided data to the RESCAN collaborators
and 15,475 people were entered into the database. The effects of covariables
(patient demographics, medical, and drug history) on AAA growth rate were
summarized in an individual patient meta-analysis. Analysis used longitudi-
nal random-affects modeling and survival analysis adjusted for aneurysm
diameter. The mean AAA growth rate was 2.21 mm/y. AAA growth was
independent of age and sex. The growth rate in smokers was increased by
0.35 mm/y, and the growth rate in patients with diabetes was decreased by
0.51 mm/y. Cardioprotective medications, mean arterial pressure, or use of
antihypertensive medications had no significant effects on AAA growth.
Calendar year of enrollment in the study was not associated with growth
rate. Rupture rates were almost fourfold higher in woman than men (P 
.001). Rupture rates were double in current smokers (P  .001) and
increased with higher blood pressure (P  .001).
Comment: The article points out that variables affecting growth of a
small AAA differ from variables affecting rupture of a small AAA. The
implications are that patients with diabetes and small AAAs perhaps can be
followed up less frequently than those without diabetes and that patients
who continue to smoke perhaps should be followed up more frequently.
With respect to rupture, the data suggest the potential of a lower threshold
for surgical intervention in women and possibly also in smokers who are
unable to successfully abstain from tobacco use. Use of drugs to modify
cardiovascular risk factors does not appear to have a major effect on growth
or rupture of small AAAs.
Midline AbdominalWall Incisional Hernia After Aortic Reconstructive
Surgery: A Prospective Study
Gruppo N, Mazzali F, Lorenzetti R, et al. Surgery 2012;151:882-8.
Conclusion: Patients with abdominal aortic aneurysm (AAA) and
aortic occlusive disease (AOD) have a similar incidence ofmidline abdominal
incisional hernia (MAIH) after midline transperitoneal aortic reconstruc-
tion. A suture length-to-wound length ratio of 4:1 is associated with
midline abdominal hernia after transperitoneal repair of AAA and AOD.
Summary:MAIH is reported in up to 11% of patients after laparotomy
and in up to 23% patients who develop midline wound infections (Hodgson
NCF et al, Ann Surg 2000;231:436-42; and Cassar K et al, Br J Surg
2002;89:534-45). Because 35% of MAIHs develop 5 years postopera-
tively, short-term observations underestimate the prevalence of MAIH after
laparotomy (Mudge M, Hughes LE, Br J Surg 1985;72:70-1). There is
controversy whether MAIH occurs more frequently after AAA repair than
after revascularization for AOD or other conditions (Adye B, Luna G, Am J
Surg 1998;175:400-2; and Johnson B et al, Cardiovasc Surg 1995:36:487-
90). Some have suggested that a possible higher incidence of MAIH in AAA
patients may reflect a genetic predisposition for a structural connective tissue
disorder in the aortic wall and the aponeurotic sheet of the abdominal
muscles. However, no specific pathogenesis has been described linking these
two disorders. In this report, the authors have evaluated the development of
MAIH after elective open repair of AAA vs revascularization for AOD.
Patients were operated on through a midline abdominal incision during a
10-year period. Data were recorded prospectively. Those patients who had a
pervious midline laparotomy or who had an MAIH after a previous laparot-
omy were excluded. Follow-up for MAIH was every 6 months for 2 years,
then yearly. Assessment for MAIH was by physical examination. When
MAIH was suspected, abdominal wall magnetic resonance imaging or
computed tomography imaging was preformed. There were 1,065 patients
who underwent aortic reconstructive surgery (412 with AAA and 653 with
AOD). Mean follow-up was 6.4  3.8 years (range, 0.5-12.7 years).
Vascular reconstruction was performed by the same vascular surgeon. Lap-
arotomy wounds were closed by three different surgeons. Closure was a
continuous running absorbable monofilament suture in a single layer with
mass closure technique. Lengths of the wound and the lengths of the suture
were measured, and a ratio of suture length/wound length was determined.
Wounds were closed with a suture length/wound length ratio of at least 4:1
in 58% of AAA patients and in 66% of AOD patients (P  .01). There were
124 (11.6%) MAIHs, with an incidence of 12.4% (51 of 412) in the AAA
group and 11.2% (73 of 653) in the AOD group (P  .062). Three wound
infections (0.4%) occurred, all in AOD patients, but none resulted in an
MAIH. Multivariate analysis showed a suture length/wound length ratio of
4:1 was the only independent predictor of MAIH in AAA ( P .004) and
AOD patients (P  .001). More than 60% of MAIHs developed between
years 1 and 2 after operation. The very large majority of the remainder was
evenly distributed between years 3 and 5.
Comment:The report’s primary finding is that the incidence ofMAIH
after aortic repair is similar for those undergoing repair for aneurysm as for
occlusive disease. This is different from the popular perception that midline
hernia is more common after AAA repair than after aortic surgery for AOD.
Possible explanations include the small number of AAA patients in many
previous investigations, the inclusion of emergency and elective AAA pro-
cedures, and inclusion in previous studies of patients with prior laparotomy
or wound infections. MAIH after midline laparotomy for aortic reconstruc-
tion therefore is perhaps best considered a multifactorial problem. When all
else is equal, rates of MAIH may not be all that different between patients
with AAA and those with AOD. In addition there seems to be no downside
of recommending a suture length/wound length ratio of at least 4:1 for
closure of midline laparotomy wounds.
Multicenter Experience on Eversion Versus Conventional Carotid
Endarterectomy in Symptomatic Carotid Artery Stenosis: Observa-
tions from the Stent-Protected Angioplasty versus Carotid Endarter-
ectomy (SPACE-1) Trial
Demirel S, Attigah N, Bruijnen H, et al; and the Space Investigators. Stroke
2012;43:1865-71.
Conclusion: Patients with cervical carotid artery stenosis undergoing
conventional carotid endarterectomy (C-CEA) have better periprocedural
outcomes than those undergoing eversionCEA (E-CEA).However, E-CEA
may be more efficacious for long-term prevention of ipsilateral stroke.
Summary: There are two basic techniques for CEA: C-CEA is per-
formed through a longitudinal arteriotomy and is generally closed with a
patch, and E-CEA is performed with an oblique transection of the internal
carotid artery off the common carotid artery with reimplantation of the
endarterectomized internal carotid artery onto the common carotid artery.
A Cochrane review in 2009 concluded that there was no evidence that one
technique was superior to the other with respect to periprocedural stroke,
death, or restenosis (Cao P et al, Cochrane Database Syst Rev 2002;1:
CD001921). In this report, the authors present a post hoc retrospective
analysis of the surgical arm of the Stent Protected Angioplasty versus Carotid
Endarterectomy trial (SPACE-1). All patients in the SPACE-1 trial were
symptomatic, and choice of CEA technique in the surgical arm was based on
surgeon preference. There were 601 eligible patients randomized into the
surgical arm of the SPACE-1 trial. After excluding patients who withdrew
consent before treatment, who did not undergo per-protocol treatment,
who experienced primary outcome before treatment, or who had CEA
without patch closure or prosthetic bypass graft interposition, there were
516 patients suitable for analysis. Of these, 310 (60.1%) underwent C-CEA
and 206 (39.9%) underwent E-CEA. The primary end point was ipsilateral
stroke or death 30 days after surgery. Secondary end points included
perioperative adverse events and the 2-year risk of restenosis, stroke, and
death. There were no restrictions with respect to type of anesthesia, neuro-
logic monitoring, heparin dose, type of patch to close the arteriotomy, or
indications for shunting. The C-CEA and E-CEA groups were similar in
demographics and baseline clinical variables. Shunt frequency was higher in
the C-CEA group (65% vs.17%; P .0001). Ipsilateral stroke or death30
days were significantly greater with E-CEA than C-CEA (9% vs 3%; P 
.005). There were no statistically significant differences in perioperative
secondary outcome events between the two groups with the exception of a
higher risk of intraoperative ipsilateral stroke in the E-CEA group (4% vs
0.3%; P  .0035). The 2-year risk of ipsilateral stroke after 30 days was
higher in the C-CEA group than in the E-CEA group (2.9% vs 0%; P 
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.017). Including perioperative events at 2 years, there were no differences
between groups in ipsilateral stroke, any stroke, disabling stroke, death, or
any stroke or death.
Comment:The study is interesting in that it suggests that the choice of
CEA technique may influence periprocedural events but not long-term
ipsilateral stroke or overall death. The limitations of this study are obvious: it
used a nonrandomized post hoc analysis, with no information about why
one CEA technique was chosen over the other, and lacked a blinded
outcome assessment. The authors also note that an infinite hazard ratio
confidence interval for ipsilateral stroke 30 days and the wide odds ratio
confidence intervals for death rates indicate that, statistically, a substantial
technique-dependent effect has not truly been ruled out by this study.
Nevertheless, this was an independently monitored, multicenter study and
therefore may have more generally applicable and accurate data than a
single-center study.
Risk of Chronic Dialysis and Death Following Acute Kidney Injury
Wald R, Quinn RR, Adhikari NK, et al. Circulation 2012;125:585-93.
Conclusion: Survivors of acute kidney injury (AKI), even when dialysis
is not required, remain at higher risk of chronic dialysis thereafter. Absolute
risk of death after AKI is more than eight times the risk of requiring chronic
dialysis after AKI.
Summary: Data indicate that modest changes in serum creatinine are
associated with adverse short-term outcomes (Chertow GM et al, J Am Soc
Nephrol 2005;16:3365-70). AKI increases risk of death after hospital dis-
charge (Wald R et al, JAMA 2009;302:1179-85). The authors hypothesize
that AKI not associated with dialysis or death will result in a higher
subsequent death rate and higher rates of long-term dialysis. This was a
population-based cohort study of patients between 1996 and 2006 in
Ontario, Canada, with the diagnosis of AKI who did not require in-hospital
dialysis and who survived dialysis-free for 30 days after hospital discharge.
Patients with AKI (n  41,327) were matched one-to-one with patients
without AKI during the index hospitalization. Factors used in matching
were age (1 year), sex, history of chronic kidney disease, use of mechanical
ventilation during the index hospitalization, and a propensity score for
developing AKI. The primary outcome was the subsequent need for chronic
dialysis, and secondary outcomes were all-cause mortality and rehospitaliza-
tion. Patients were a mean age of 70 years, and median follow-up was 2 years
(maximum, 10 years). The incident of chronic dialysis was 1.78/100 per-
son-years in the patients with AKI and 0.74/100 person-years in unaffected
controls (adjusted hazard ratio 2.7, 95% confidence interval [CI], 2.42-
3.00). Among the patients with AKI, rates were also higher for all-cause
mortality (15.34 vs 14.51/100 person-years; adjusted HR, 1.1; 95% CI,
1.07-1.13) and rehospitalization (44.93 vs 37.18/100 person years; ad-
justed HR, 1.21; 95% CI, 1.18-1.24).
Comment: The data in the study were derived from a diverse group of
patients with multiple primary diagnoses. The authors, however, did present
subgroup analysis. With the exception of patients with pre-existing chronic
kidney diseases and diabetes mellitus, the incidence of chronic dialysis after
AKI in patients with peripheral vascular disease was higher than in those with
all other diagnosis, including patients with myocardial infarction, cerebral
vascular disease, those undergoing cardiac surgery, those having suffered an
episode of sepsis, and those undergoing abdominal aortic aneurysm repair.
The data were not stratified for magnitude of recovery after AKI; however,
by 10 years of follow-up, the patients whose hospitalization included AKI
had an 12% risk of chronic dialysis. Even if a patient “recovers” renal
function after AKI, patients with AKI never truly fully “recover.” They
remain at a relative high risk for chronic dialysis and death compared with
matched controls without AKI.
The United States Registry for Fibromuscular Dysplasia: Results in the
First 447 Patients
Olin JW, Froehlich J, Ziaokui G. Circulation 2012;125:3182-90.
Conclusion: Fibromuscular dysplasia (FMD) occurs primarily in middle-
aged women but presents across all ages. Cerebrovascular FMD and renal
FMD occur equally frequently. Many patients with FMD present with
nonspecific symptoms that result in a delay in diagnosis.
Summary: FMD is a noninflammatory vascular disease that most
commonly affects the extracranial carotid and renal arteries. Patients with
renal artery involvement may present with hypertension, and those with
carotid artery involvement may have transient ischemic attacks, stroke,
pulsatile tinnitus, or headache. The prevalence of FMD in the general
population has not been studied, but 4% of patients who undergo renal
angiography have FMD (Cragg AH et al, Radiology 1989;172:145-7).
Most information on FMD consists of case series, and little new information
has been published in the past 30 years. The authors developed a registry for
FMD with the goal of better understanding the epidemiology of FMD and
the management and outcomes of patients with FMD. This report includes
the first 447 adult patients entered into the registry. The authors reviewed
clinical features, presenting symptoms, and vascular events for these patients
enrolled from nine United States sites. Vascular beds were imaged selectively
based on clinical presentation and local practice. Patients (91% female) were
a mean age at diagnosis of 51.9 years (standard deviation, 13.4; range, 5-83
years). Hypertension, headache, and pulsatile tinnitus were the most com-
mon presenting symptoms. FMD in first- or second-degree relatives was
reported only in 7.3%, but there were self-reported family histories of stroke
in 53.5%, aneurysm disease in 23.5%, and sudden death in 19.8%. FMD was
identified in the renal arteries in 294 patients and in the extracranial carotid
artery in 251, with 82 having vertebral artery involvement. Transient isch-
emic attack or stroke had occurred in 19.2% of the patients, arterial dissec-
tion in 19.7%, and aneurysms in 17%. Indications for therapy were primarily
hypertension, aneurysm, and dissection.
Comment: There are a number of interesting points here. First, renal
and cerebral vascular FMD appear to occur with relatively equal frequency.
One in five patients experience a dissection and 17% have an aneurysm;
however, only 20% of patients have lateralizing neurologic events. The
authors appropriately emphasize that the presence of a carotid bruit in a
patient aged 60 years or an epigastric bruit in a patient with hypertension
should bring to mind the possible diagnosis of FMD so that appropriate
treatment can be applied and the consequences of poorly controlled hyper-
tension avoided and aneurysms and dissections identified.
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